Must Asset Management’s Novo Nordisk NVO Stock Holding History

Must Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$609K	Hold	6,636	–	–	1.49%	15
2023 Q2	$521K	Buy	+6,636	New	+$542K	1.44%	14

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Must Asset Management's NVO Position: Q3 2023 in Review

Must Asset Management held its Novo Nordisk (NVO) position steady in Q3 2023 at 6,636 shares worth $609K. The position accounts for 1.49% of the portfolio, ranked #15.

Must Asset Management first reported a position in NVO in Q2 2023 and has held it in 2 quarters since. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

Must Asset Management held 6,636 shares of Novo Nordisk worth $609K as of Q3 2023.
Must Asset Management left its Novo Nordisk share count unchanged in Q3 2023.
Novo Nordisk made up 1.49% of Must Asset Management's portfolio in Q3 2023, its #15 holding.
Must Asset Management first reported a position in Novo Nordisk in Q2 2023 and has held it in 2 quarters since.
1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Must Asset Management's 13F filing for Q3 2023, filed 7 Nov 2023.